[Change in regulations for dispensing immunosuppressants to patients who have undergone a kidney transplant].
J
J
Gulín Dávila
L
L
López Rodríguez
D057176:Compassionate Use Trials / Q000941:ethics / Q000331:legislation & jurisprudence*; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D016527:Drug Costs; D011307:Drug Prescriptions; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control*; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006297:Health Services Accessibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007258:Informed Consent; D016030:Kidney Transplantation; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D056687:Off-Label Use / Q000941:ethics / Q000331:legislation & jurisprudence*; D010594:Pharmacies / Q000191:economics / Q000331:legislation & jurisprudence*; D010607:Pharmacy Service, Hospital; D011788:Quality of Life; D012424:Rural Population; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use; D013030:Spain
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D020123:Sirolimus